Odyssey Investment Partners, LLC announces that it has acquired BarrierSafe Solutions International, Inc., a provider of disposable gloves, from Linden Capital Partners and The Edgewater Funds. Financial terms of the transaction were not disclosed.
Based in Lake Forest, Ill., BarrierSafe is a player in the $2 billion U.S. disposable protective glove segment of the personal protective equipment industry. The company designs, develops and markets a comprehensive suite of disposable gloves and other related products that serve the needs of users across a diverse range of growing, niche markets that enjoy favorable regulatory and secular tailwinds. Formed in 2004 through the merger of two industry leaders, Microflex and FoodHandler, BarrierSafe today provides in excess of six billion single-use gloves annually.
Odyssey has prior experience in the personal protective equipment industry through its investment in Norcross Safety Products, a leading provider of safety products to the fire, general safety and electric utility end markets. Norcross was sold to Honeywell International in 2008. Robert Peterson and David Myers, Norcross' former CEO and CFO, respectively, are co-investing with Odyssey and will join the BarrierSafe board of directors.
Randy Paulson, managing principal of Odyssey, says, "We are excited to invest again in the safety sector through BarrierSafe and to partner with the Company's extremely talented management team. We expect to create value for our investors by capitalizing on BarrierSafe's strong market positions and compelling growth opportunities, including acquisitions."
The BarrierSafe management team, led by CEO Mike Mattos and CFO/COO Joe Kubicek, will continue to lead the company under Odyssey's ownership. The management team has invested in BarrierSafe alongside Odyssey.
Debt financing for the transaction will consist of a senior secured facility led by CIT Capital and SunTrust and mezzanine financing provided by Morgan Stanley Credit Partners.
An Ounce of Prevention: Managing Influenza and COVID-19 in Long-Term Care
September 10th 2024As influenza and COVID-19 circulate in long-term care facilities, prompt testing, isolation precautions, and antiviral treatments are crucial for preventing outbreaks and protecting vulnerable residents.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.
The Long-Term Care Chronicles: The Great Mitigators
August 27th 2024Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.